A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER
Journal article published in 2020 by
Jonathan W. Goldman,
Julien Mazieres,
Fabrice Barlesi,
Konstantin H. Dragnev,
Marianna Koczywas,
Tuncay Göskel,
Alexis B. Cortot,
Nicolas Girard,
Claas Wesseler 
,
Helge Bischoff,
Ernest Nadal,
Keunchil Park,
Shun Lu,
Alvaro Taus,
Manuel Cobo
and other authors.
,
Helge Bischoff,
Ernest Nadal,
Keunchil Park,
Shun Lu,
Alvaro Taus,
Manuel Cobo
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 